Wharton's jelly derived Mesenchymal stem cells.

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Wharton's jelly derived Mesenchymal stem cells.
Treatment and conditionWhere it standsTrials
Wharton's jelly derived Mesenchymal stem cells. for coronavirus infectionsTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Wharton's jelly derived Mesenchymal stem cells. for respiratory distress syndromeTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1